The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care.
10.3350/kjhep.2011.17.3.189
- Author:
Hyuk Soo EUN
1
;
Min Jung KIM
;
Hye Jin KIM
;
Kwang Hun KO
;
Hee Seok MOON
;
Eaum Seok LEE
;
Seok Hyun KIM
;
Heon Young LEE
;
Byung Seok LEE
Author Information
1. Division of Gastroenterology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea. gie001@cnuh.co.kr
- Publication Type:Original Article
- Keywords:
Hepatocellular carcinoma;
Radiotherapy;
Survival rate;
Alpha-fetoprotein;
Child-Pugh class
- MeSH:
Aged;
Carcinoma, Hepatocellular/mortality/pathology/*radiotherapy;
Chemoembolization, Therapeutic;
Cohort Studies;
Female;
Humans;
Liver Neoplasms/mortality/pathology/*radiotherapy;
Male;
Middle Aged;
*Palliative Care;
Prognosis;
Retrospective Studies;
Severity of Illness Index;
Survival Analysis;
alpha-Fetoproteins/analysis
- From:The Korean Journal of Hepatology
2011;17(3):189-198
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: This study was conducted to investigate the assessment of treatment efficacy of radiotherapy (RT) and other therapeutic modalities compared with palliative care only for treatment with advanced hepatocellular carcinoma (HCC). METHODS: From 2002 to 2010, based on the case of 47 patients with advanced HCC, we have investigated each patients' Child-Pugh's class, ECOG performance, serum level of alpha fetoprotein and other baseline characteristics that is considered to be predictive variables and values for prognosis of HCC. Out of overall patients, the 29 patients who had received RT were selected for one group and the 18 patients who had received only palliative care were classified for the other. The analysis in survival between the two groups was done to investigate the efficacy of RT. RESULTS: Under the analysis in survival, the mean survival time of total patients group was revealed between 30.1 months and 45.9 months in RT group, while it was 4.8 months in palliative care group, respectively. In the univariate analysis for overall patients, there were significant factors which affected survival rate like as follows: ECOG performance, Child-Pugh's class, the tumor size, the type of tumor, alpha fetoprotein, transarterial chemoembolization, and RT. The regressive analysis in multivariate Cox for total patients. No treatment under radiotherapy and high level of Child-Pugh's class grade were independent predictors of worse overall survival rate in patients. In contrast, for the subset analysis of the twenty-nine patients treated with radiotherapy, the higher serum level of alpha fetoprotein was an independent predictors of worse overall survival rate in patients. CONCLUSIONS: We found that the survival of patients with advanced HCC was better with radiotherapy than with palliative care. Therefore, radiotherapy could be a good option for in patients with advanced HCC.
